Skip to content

Sotera Health Company

US · SHC #2097 by market cap Listed 2020
15.91 -0.30 -1.85%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:00

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 20 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.9 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
101.34% -1.93pp
Institutions
386 +20
As of
2026/Q3 vs. prior period

Holder types

Hedge Fund49.03%
Mutual Fund46.80%
Public Company2.58%
Individual/Insider2.18%
Sovereign Wealth Fund1.26%
Government Pension Fund0.69%
Private Company0.63%
Insurance Company0.17%

Top holders as of 2026-06-30

Sessa Capital IM, L.P. 9.47% · 27.05M sh
Darsana Capital Partners LP 9.45% · 27.00M sh
BlackRock 9.03% · 25.78M sh
Sculptor Capital Management, Inc. 8.40% · 24.00M sh
Vanguard Capital Management, LLC 4.34% · 12.39M sh
Sachem Head Capital Management LP 5.45% · 15.56M sh
Vanguard Portfolio Management, LLC 4.11% · 11.75M sh
T. Rowe Price Group, Inc. 3.77% · 10.78M sh
AQR Capital Management 3.74% · 10.69M sh
State Street Global Advisors 3.06% · 8.75M sh
Janus Henderson Group plc 2.94% · 8.40M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 23 sells

NameRoleStake
Michael Petras Executive Chairperson 1.53%
Alton Shader Chief Executive Officer 0.20%
Alexander Dimitrief Former Senior Vice President 0.10%
Michael Rutz President of Sterigenics U.S., LLC 0.09%
Ann Klee Independent Director 0.04%
Jonathan Lyons Senior Vice President 0.04%
Sean Cunningham Independent Director 0.03%
Ruoxi Chen Independent Director 0.03%
James Neary Former Independent Director 0.03%
Vincent Petrella Lead Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-16 Michael Petras Executive Chairperson Open Market Disposition -1,144,515 $18.50
2026-08-06 Michael Rutz President of Sterigenics U.S., LLC Open Market Disposition -150,000 $18.84
2026-08-04 Jonathan Lyons Senior Vice President Sale to Issuer -11,316 $17.98
2026-05-25 Alton Shader Chief Executive Officer Other Acquisition +579,573 --
2026-05-25 Alton Shader Chief Executive Officer Other Derivative Acquisition +101,817 --
2026-05-21 James Neary Former Independent Director Other Acquisition +14,970 --
2026-05-21 Sean Cunningham Independent Director Other Acquisition +14,970 --
2026-05-21 Vincent Petrella Lead Independent Director Other Acquisition +14,970 --
2026-05-21 Christopher Simon Independent Director Other Acquisition +14,970 --
2026-05-21 Ann Klee Independent Director Other Acquisition +14,970 --
2026-05-21 Ruoxi Chen Independent Director Other Acquisition +14,970 --
2026-05-21 David Wheadon Independent Director Other Acquisition +14,970 --
2026-05-21 Richard Kyle Independent Director Other Acquisition +14,970 --
2026-05-21 Karen Flynn Independent Director Other Acquisition +14,970 --
2026-05-21 Kenneth Krause Independent Director Other Acquisition +14,970 --
2026-05-12 Warburg Pincus LLC -- Private Disposition -19,102,952 $15.17
2026-05-12 GTCR LLC -- Private Disposition -12,654,291 $15.17
2026-03-31 Erika Ostrowski Senior Vice President Initial Statement of Beneficial 0 --
2026-03-30 Alexander Dimitrief Former Senior Vice President Sale to Issuer -7,941 $14.34
2026-03-01 Alexander Dimitrief Former Senior Vice President Sale to Issuer -14,744 $15.91

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 16:00:57 · For reference only, not investment advice and not tailored to your situation.

Sotera Health Company discussion 0 comments

Add a comment